Coalition Opposes Durbin Amendment to Compel Biopharmaceutical Companies to Include List Prices in Direct-To-Consumer Advertisements
July 27, 2018
Open Letter to the U.S. Senate: Coalition Opposes Durbin Amendment to Compel Biopharmaceutical Companies to Include List Prices in Direct-To-Consumer Advertisements
Dear Senator:
